--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About VTYX20260220C15
Pharmaceutical
Ventyx Biosciences, Inc., was incorporated in Delaware on November 21, 2018. The company is a clinical-stage biopharmaceutical company focused on developing new therapies for millions of patients with inflammatory and autoimmune diseases. The company believes that their ability to selectively modulate key immune targets to create differentiated drugs will make it possible for them to disrupt the mature multi-billion dollar commercial market and make them a leader in the immunology market.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
